Why the study?
Experimental coronary interventions are typically performed on non-diseased vessels in healthy animals, creating a need for a stenotic lesion mimicking human atherosclerotic plaque to provide a more realistic pathoanatomical scenario.
Can an artificial atherosclerotic plaque be engineered to mimic human plaque morphology and be successfully inserted into a porcine coronary artery model?
Population
Resected pig hearts and in vitro setups
Design
Preclinical experimental and bioengineering study
Key result
An artificial atherosclerotic plaque composed of gelatin, cholesterol, phospholipids, hydroxyapatite, and calcium carbonate successfully mimicked the mechanical properties of human plaques and was implantable in porcine coronary arteries.
Authors
Loading...
May enable preclinical coronary intervention testing in a realistic stenosis model; leaves open human translation pending validation.
Can an artificial atherosclerotic plaque be engineered to mimic human plaque morphology and be successfully inserted into a porcine coronary artery model?
The development of an artificial atherosclerotic plaque model for porcine coronary arteries provides a realistic pathoanatomical tool for future preclinical testing of interventional and surgical therapies.
Lindenhahn et al. (2024) studied Coronary Heart Disease. Artificial atherosclerotic plaque (AAP) was evaluated on Mechanical properties and implantability. An artificial atherosclerotic plaque composed of gelatin, cholesterol, phospholipids, hydroxyapatite, and calcium carbonate successfully mimicked the mechanical properties of human plaques and was implantable in porcine coronary arteries.